GT Biopharma, Inc. (GTBP)

GT Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	6	11	29	93	36	5
Market Cap Growth	-69.79%	-63.37%	-69.01%	159.67%	556.05%	-83.27%
Enterprise Value	-4	-5	8	57	58	18
Last Close Price	4.43	7.65	26.57	91.50	216.24	41.31
PE Ratio	-	-1.36	-1.35	-1.48	-1.12	-0.12
PB Ratio	1.10	1.41	2.46	4.25	-1.22	-0.28
P/FCF Ratio	-0.61	-1.19	-1.90	-5.96	-4.93	-1.49
P/OCF Ratio	-0.61	-1.19	-1.90	-5.96	-4.93	-1.49
EV/EBITDA Ratio	-	-	-	-	-8.65	-1.60
EV/EBIT Ratio	0.60	0.39	-0.39	-0.99	-8.64	-1.60
EV/FCF Ratio	0.77	0.61	-0.54	-3.67	-8.05	-5.00
Debt / Equity Ratio	0.01	0.01	0.01	0.00	-0.89	-0.69
Debt / FCF Ratio	0.00	-0.01	-0.01	0.00	-3.63	-3.65
Quick Ratio	2.13	2.11	3.34	3.12	0.15	0.00
Current Ratio	2.15	2.12	3.35	3.14	0.16	0.01
Return on Equity (ROE)	-104.94%	-79.09%	-124.15%	-	-	-
Return on Assets (ROA)	-54.18%	-55.02%	-54.33%	-190.04%	-139.59%	-55.52%
Return on Capital (ROIC)	-87.65%	-87.29%	-78.50%	-381.56%	-	-88.28%
Earnings Yield	-164.27%	-71.93%	-72.42%	-62.35%	-78.97%	-707.56%
FCF Yield	-172.33%	-83.81%	-52.77%	-16.77%	-20.27%	-66.99%
Buyback Yield / Dilution	-27.50%	-26.87%	-13.19%	-542.06%	-29.59%	-14.50%
Total Shareholder Return	-27.50%	-26.87%	-13.19%	-542.06%	-29.59%	-14.50%

Source: S&P Capital IQ. Standard template.